Counsel Portfolio Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$6.43M Hold
87,036
0.64% 42
2016
Q1
$5.65M Sell
87,036
-36,731
-30% -$2.5M 0.74% 36
2015
Q4
$9.54M Buy
123,767
+9,251
+8% +$735K 1% 14
2015
Q3
$9.43M Buy
114,516
+12,834
+13% +$1.14M 1.02% 14
2015
Q2
$8.96M Buy
101,682
+7,923
+8% +$727K 0.91% 16
2015
Q1
$8.29M Buy
93,759
+43,539
+87% +$3.86M 0.83% 21
2014
Q4
$4.17M Sell
50,220
-2,232
-4% -$185K 0.42% 73
2014
Q3
$4.42M Buy
52,452
+7,812
+18% +$632K 0.46% 71
2014
Q2
$3.62M Sell
44,640
-6,919
-13% -$544K 0.34% 91
2014
Q1
$3.93M Hold
51,559
0.39% 83
2013
Q4
$3.71M Buy
51,559
+19,976
+63% +$1.39M 0.38% 81
2013
Q3
$2.17K Buy
31,583
+3,324
+12% +$220K 0.11% 119
2013
Q2
$1.79M Buy
+28,259
New +$1.84M 0.22% 134

Other funds holding NVS

Counsel Portfolio Services's NVS Position: Q2 2016 in Review

Counsel Portfolio Services held its Novartis (NVS) position steady in Q2 2016 at 87,036 shares worth $6.43M. The position accounts for 0.64% of the portfolio, ranked #42.

Counsel Portfolio Services first reported a position in NVS in Q2 2013 and has held it in 13 quarters since. The position peaked at $9.54M in Q4 2015. 879 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

  • Counsel Portfolio Services held 87,036 shares of Novartis worth $6.43M as of Q2 2016.
  • Counsel Portfolio Services left its Novartis share count unchanged in Q2 2016.
  • Novartis made up 0.64% of Counsel Portfolio Services's portfolio in Q2 2016, its #42 holding.
  • Counsel Portfolio Services first reported a position in Novartis in Q2 2013 and has held it in 13 quarters since.
  • Counsel Portfolio Services's Novartis position peaked at $9.54M in Q4 2015.
  • 879 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Counsel Portfolio Services's 13F filing for Q2 2016, filed 12 Aug 2016.